Antitumor effect of MAb EMD 55900 depends on EGF-R expression and histopathology

Neoplasia

Volumn 4, Issue 3, 2002, Pages 237-242

  Solbach, Christine ^a   Sterner Kock, Anja ^a   Roller, Marc ^a   Schnürch, Hans Georg ^a   Stegmüller, Manfred ^a   Caspar Bell, Gudrun ^b   Schumm Draeger, Petra Maria ^b   Kaufmann, Manfred ^a   Knecht, Rainald ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Lukaskrankenhaus GmbH   (Germany)

Author keywords

Antibody; EGFR; EMD 55900; EMD 72000; Histology

Indexed keywords

EMD 55900; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONNECTIVE TISSUE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EPITHELIUM CELL; GROWTH INHIBITION; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; XENOTRANSPLANTATION;

EID: 0036097485     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj/neo/7900236     Document Type: Article

References (25)

1. Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research
2. Untangling the ErbB signaling network
3. Localization and modulation of ErbB receptor tyrosine kinases
4. EGF receptor
5. The erbB-2/Her2 oncoprotein of human carcinomas may function solely as shared coreceptor for multiple stroma-derived growth factors
6. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
7. ErbB oncogenes and EGF-like ligands: Cell lineage determination and oncogenesis through combinatorial signaling
8. Oncogenes related to head and neck cancer
9. Epidermal growth factor receptors in non-small cell lung cancer
10. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo
11. The EGF receptor family as targets for cancer therapy
12. Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide
13. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha
14. Growth inhibition of xenotransplanted human carcinoma by a monoclonal antibody directed against the epidermal growth factor receptor
15. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival
16. Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer
17. (KIP1) independent of MAPK activity
18. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors
19. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model
20. Monoclonal antibody therapies - A "constant" threat to cancer
21. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing ortotopically in nude mice
22. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor
23. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T
24. A role of PDGFR alpha in basal cell carcinoma proliferation